INTERNATIONAL PATENT: TAICHENGSI (SHANGHAI) BIOMEDICAL CO., LTD., 泰诚思（上海）生物医药有限公司 FILES APPLICATION FOR "HYDROPHILIC LINKER, INTERMEDIATE OF LINKER, LINKER-DRUG CONJUGATE, ANTIBODY-DRUG CONJUGATE AND USE THEREOF"

Posted On: 2026-02-23

GENEVA, Feb. 23 -- TAICHENGSI (SHANGHAI) BIOMEDICAL CO., LTD. (2nd Floor, Unit 3, Building 10, No. 160 Basheng Road, China (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 200131), 泰诚思（上海）生物医药有限公司 (中国上海市浦东新区中国（上海）自由贸易试验区巴圣路160号10幢3单元2层) filed a patent application (PCT/CN2025/113730) for "HYDROPHILIC LINKER, INTERMEDIATE OF LINKER, LINKER-DRUG CONJUGATE, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF" on Aug 09, 2025. With public...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: TAICHENGSI (SHANGHAI) BIOMEDICAL CO., LTD., 泰诚思（上海）生物医药有限公司 FILES APPLICATION FOR "HYDROPHILIC LINKER, INTERMEDIATE OF LINKER, LINKER-DRUG CONJUGATE, ANTIBODY-DRUG CONJUGATE AND USE THEREOF"